NOV 12, 2020 3:00 PM PST

Translating insights into better outcomes: The new QIAseq Human Exome integrated solution

Sponsored by: QIAGEN
C.E. Credits: P.A.C.E. CE Florida CE
Speakers

Abstract

What if your lab could perform exome sequencing with the same sensitivity and efficiency of targeted sequencing? The new integrated QIAseq Human Exome TR Insights solution from QIAGEN delivers the best of both worlds. Consisting of three seamlessly integrated components – the QIAseq Human Exome Panel, QIAGEN CLC Genomics Workbench and QCI Interpret Translational – this innovative solution combines highly specific and uniform exome coverage with streamlined secondary analysis, rapid variant filtering and variant annotation to help labs quickly and confidently deliver disease-related insights at scale. Join us for a presentation where we will discuss the new solution in detail, focusing on the following: • Technical overview and performance data on exome enrichment • Accelerating and standardizing your variant detection and calling • Rapid triage and annotation of variants with full transparency, leveraging powerful algorithms and manually-curated content from over 40 databases • Data analysis and interpretation demonstration with QCI Interpret Translational The integrated QIAseq Human Exome solution translates insights into better outcomes, enabling labs to scale up efficiently. Speakers: Brian Dugan, Associate Director, Global Product Management Genomics Rupert Yip, Ph.D., Director of Clinical Genomics, Genetic Disease Informatics

Learning Objectives:

1. Technical performance of the QIAseq Human Exome Kit and how the workflow can decrease turnaround time and cost

2. How to accelerate and standardize your data analysis and variant calling

3. How to use QCI-Translational to rapidly interpret variants with access to over 40 curated databases


Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
OCT 20, 2021 10:00 AM PDT
C.E. CREDITS
OCT 20, 2021 10:00 AM PDT
Date: October 20, 2021 Time:10:00am (PDT), 1:00pm (EDT) As the prevalence of Diabetes continues to rise in many areas across the globe, healthcare providers continue to look for methods that...
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
JUL 15, 2021 8:00 AM PDT
C.E. CREDITS
JUL 15, 2021 8:00 AM PDT
Date: July 15, 2021 Time: 8:00am (PDT), 11:00am (EDT) High dimensional full spectrum flow cytometry grants unprecedented access to previously unattainable parameters in cellular biology. Flu...
Loading Comments...
Show Resources